Publication | Closed Access
Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial
86
Citations
33
References
2020
Year
Drug TargetingOncologyMedicineLiposomal DoxorubicinTumor TargetingAnti-cancer AgentCancer TreatmentPhase 2PharmacologyRadiation OncologyOvarian Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1